Pfizer Inc. (PFE)
27.79
-0.66
(-2.32%)
USD |
NYSE |
Sep 08, 15:59
27.82
+0.03
(+0.11%)
After-Hours: 20:00
Pfizer Market Cap : 158.38B for Sept. 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 04, 2026 | 162.14B |
| September 03, 2026 | 164.19B |
| September 02, 2026 | 165.38B |
| September 01, 2026 | 162.71B |
| August 31, 2026 | 162.19B |
| August 28, 2026 | 159.34B |
| August 27, 2026 | 159.69B |
| August 26, 2026 | 161.28B |
| August 25, 2026 | 162.82B |
| August 24, 2026 | 159.40B |
| August 21, 2026 | 159.97B |
| August 20, 2026 | 158.38B |
| August 19, 2026 | 160.94B |
| August 18, 2026 | 155.30B |
| August 17, 2026 | 153.13B |
| August 14, 2026 | 152.68B |
| August 13, 2026 | 152.73B |
| August 12, 2026 | 149.94B |
| August 11, 2026 | 151.71B |
| August 10, 2026 | 154.16B |
| August 07, 2026 | 152.51B |
| August 06, 2026 | 149.31B |
| August 05, 2026 | 147.09B |
| August 04, 2026 | 144.81B |
| August 03, 2026 | 142.65B |
| Date | Value |
|---|---|
| July 31, 2026 | 142.53B |
| July 30, 2026 | 141.96B |
| July 29, 2026 | 143.33B |
| July 28, 2026 | 143.90B |
| July 27, 2026 | 140.59B |
| July 24, 2026 | 139.85B |
| July 23, 2026 | 142.53B |
| July 22, 2026 | 141.45B |
| July 21, 2026 | 142.13B |
| July 20, 2026 | 141.05B |
| July 17, 2026 | 142.76B |
| July 16, 2026 | 143.27B |
| July 15, 2026 | 141.45B |
| July 14, 2026 | 138.20B |
| July 13, 2026 | 139.51B |
| July 10, 2026 | 137.74B |
| July 09, 2026 | 138.20B |
| July 08, 2026 | 137.06B |
| July 07, 2026 | 137.17B |
| July 06, 2026 | 135.18B |
| July 02, 2026 | 138.60B |
| July 01, 2026 | 136.09B |
| June 30, 2026 | 137.23B |
| June 29, 2026 | 138.88B |
| June 26, 2026 | 138.43B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 648.20B |
| Eli Lilly & Co. | 1.058T |
| Merck & Co., Inc. | 366.54B |
| Bristol Myers Squibb Co. | 132.16B |
| Viatris, Inc. | 19.19B |
Market Cap Related Metrics
| PE Ratio | 36.80 |
| PS Ratio | 2.490 |
| Price to Book Value | 1.859 |
| Price to Free Cash Flow | 14.44 |
| Price | 27.79 |
| Earnings Yield | 2.72% |
| Operating PE Ratio | 9.370 |
| Normalized PE Ratio | 11.47 |